Lv4
730 积分 2021-08-11 加入
Adherence to medication
2天前
已完结
Functional precision oncology using patient-derived assays: bridging genotype and phenotype
14天前
已完结
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
1个月前
已完结
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
1个月前
已完结
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial
2个月前
已完结
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
2个月前
已完结
Wide application of a novel topoisomerase I inhibitor-based drug conjugation technology
2个月前
已完结
皖公网安备34019202002308
